Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 10
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    de Cellès, Matthieu Domenech Pons-Salort, Margarita Varon, Emmanuelle Vibet, Marie-Anne Ligier, Caroline Letort, Véronique Opatowski, Lulla and Guillemot, Didier 2015. Interaction of Vaccination and Reduction of Antibiotic Use Drives Unexpected Increase of Pneumococcal Meningitis. Scientific Reports, Vol. 5, p. 11293.

    Ampofo, Krow Pavia, Andrew T. Chris, Stockmann Hersh, Adam L. Bender, Jeffrey M. Blaschke, Anne J. Weng, Hsin Yi Cindy Korgenski, Kent E. Daly, Judy Mason, Edward O. and Byington, Carrie L. 2012. The Changing Epidemiology of Invasive Pneumococcal Disease at a Tertiary Childrenʼs Hospital Through the 7-valent Pneumococcal Conjugate Vaccine Era. The Pediatric Infectious Disease Journal, Vol. 31, Issue. 3, p. 228.

    Opatowski, Lulla Guillemot, Didier Boëlle, Pierre-Yves and Temime, Laura 2011. Contribution of mathematical modeling to the fight against bacterial antibiotic resistance. Current Opinion in Infectious Diseases, Vol. 24, Issue. 3, p. 279.

    Van Effelterre, Thierry Moore, Matthew R. Fierens, Frederik Whitney, Cynthia G. White, Lisa Pelton, Stephen I. and Hausdorff, William P. 2010. A dynamic model of pneumococcal infection in the United States: Implications for prevention through vaccination. Vaccine, Vol. 28, Issue. 21, p. 3650.

    Hsu, Heather E. Shutt, Kathleen A. Moore, Matthew R. Beall, Bernard W. Bennett, Nancy M. Craig, Allen S. Farley, Monica M. Jorgensen, James H. Lexau, Catherine A. Petit, Susan Reingold, Arthur Schaffner, William Thomas, Ann Whitney, Cynthia G. and Harrison, Lee H. 2009. Effect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis. New England Journal of Medicine, Vol. 360, Issue. 3, p. 244.

    Dagan, Ron and Klugman, Keith P 2008. Impact of conjugate pneumococcal vaccines on antibiotic resistance. The Lancet Infectious Diseases, Vol. 8, Issue. 12, p. 785.

    TEMIME, L. HEJBLUM, G. SETBON, M. and VALLERON, A. J. 2008. The rising impact of mathematical modelling in epidemiology: antibiotic resistance research as a case study. Epidemiology and Infection, Vol. 136, Issue. 03,

    Temime, L. and Dab, W. 2007. Vaccination antipneumococcique : bénéfices attendus chez l'adulte. La Revue de Médecine Interne, Vol. 28, Issue. 1, p. 9.

    Dagan, Ron Barkai, Galia Leibovitz, Eugene Dreifuss, Eli and Greenberg, David 2006. Will Reduction of Antibiotic Use Reduce Antibiotic Resistance?. The Pediatric Infectious Disease Journal, Vol. 25, Issue. 10, p. 981.

    Temime, Laura Guillemot, Didier and Bo??lle, Pierre-Yves 2006. Pneumococcal Resistance in the Postvaccine Era. The Pediatric Infectious Disease Journal, Vol. 25, Issue. 4, p. 382.


Penicillin-resistant pneumococcal meningitis: high antibiotic exposure impedes new vaccine protection

  • L. TEMIME (a1), P. Y. BOËLLE (a1) (a2), A. J. VALLERON (a1) (a2) and D. GUILLEMOT (a3)
  • DOI:
  • Published online: 01 January 2005

The frequency of meningitis due to penicillin-resistant Streptococcus pneumoniae (PRP) has increased in recent years, making treatment failure more likely. It is currently expected that pneumococcal conjugate vaccines might curb this trend. We investigated this issue using a mathematical model applied to the current prevalence of resistance and antibiotic exposure in the United States and in France. Our main finding was that the level of antibiotic exposure may limit the effect of the vaccine. In relatively low antibiotic exposure environments such as the United States, large-scale vaccination prevents a large part of PRP meningitis cases, whereas in high antibiotic-exposure environments such as France, vaccination alone does not lead to a substantial reduction in PRP meningitis incidence. Our results suggest that antibiotic exposure reduction will remain of primary importance for the control of PRP meningitis despite wide scale use of pneumococcal conjugate vaccines.

Corresponding author
Chaire Hygiène et Securité, CNAM, 2 rue Conté, 75141 Paris Cedex 03, France. (Email:
Hide All
This work was presented in part at the 13th ECCMID, Glasgow, 2003 (abstract O73).
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *